← Back to Clinical Trials
Recruiting NCT06249880

NCT06249880 Pediatric Normative Markerless Movement Analysis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06249880
Status Recruiting
Phase
Sponsor MultiCare Health System Research Institute
Condition Pediatric ALL
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-03-01
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 25 Years
Study Type OBSERVATIONAL
Interventions
Observation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-03-01 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.

Eligibility Criteria

Inclusion Criteria: * Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion). * Ambulate independently and without the use of assistive devices or orthoses. * Willing and interested in participating. Exclusion Criteria: * Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues. * Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity. * Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment. * History of premature birth. * Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.

Contact & Investigator

Central Contact

Brenna Brandsma, PT, DPT, PCS

✉ brenna.brandsma@multicare.org

📞 253-697-5268

Principal Investigator

Brenna Brandsma

PRINCIPAL INVESTIGATOR

Mary Bridge Chidlren's

Frequently Asked Questions

Who can join the NCT06249880 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 25 Years, studying Pediatric ALL. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06249880 currently recruiting?

Yes, NCT06249880 is actively recruiting participants. Contact the research team at brenna.brandsma@multicare.org for enrollment information.

Where is the NCT06249880 trial being conducted?

This trial is being conducted at Puyallup, United States.

Who is sponsoring the NCT06249880 clinical trial?

NCT06249880 is sponsored by MultiCare Health System Research Institute. The principal investigator is Brenna Brandsma at Mary Bridge Chidlren's. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology